Abstract
The IRIS mitral annuloplasty ring is a transcatheter, transfemoral and transseptal-delivered complete, semi-rigid annuloplasty ring. The IRIS system mimics surgical annuloplasty by reducing the mitral septal-lateral dimension and improving leaflet coaptation. We report the early experience with the IRIS system in seven patients. These patients had 3-4+ mitral regurgitation (MR) with annular dilation and were symptomatic NYHA II-IV with LV end systolic dimensions ≤ 65 mm. Patients were excluded for LVEF < 20%, aortic valve disease, right-sided heart failure and PA systolic pressure > 70 mmHg. Baseline and 30-day transthoracic echocardiography and CT imaging was performed. In phase 1, 4 patients had surgical IRIS mitral ring implantation. In phase 2, 3 patients had transfemoral, transseptal delivery of the IRIS mitral ring. There was no procedural death, or MI. The mitral SL diameter was reduced from 38.0±4.1 to 25.9±4.9 mm at 30 days (31.8% SL reduction, n=7). MR was reduced from baseline 3-4+ to 0-1+ in all patients at 30 days. There were improvements in NYHA class and there was a decrease in diastolic LV volumes from 182.4±54.3 to 115.3±98.8 mL at 30 days (36.8% reduction). Based on these initial positive findings, ongoing clinical trials are underway to further evaluate the safety and efficacy of the IRIS ring.
Original language | English (US) |
---|---|
Pages (from-to) | 780-786 |
Number of pages | 7 |
Journal | Annals of Cardiothoracic Surgery |
Volume | 7 |
Issue number | 6 |
DOIs | |
State | Published - Nov 1 2018 |
Keywords
- Mitral annuloplasty
- Mitral regurgitation
- Transcatheter mitral valve repair
ASJC Scopus subject areas
- Surgery
- Cardiology and Cardiovascular Medicine